Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell

Clover's profitability metrics are improving but remain dismal, while the firm appears to lack strong, competitive advantages. As a result, CLOV stock is a sell.

Is CHWY Stock a Buy After Earnings Plunge? 3 Analysts Weigh In on Chewy Prices.

After Chewy reported a worse-than-expected Q4 loss per share, analysts were generally cautious on CHWY stock.

Is LULU Stock a Buy After Earnings? 3 Analysts Weigh In on Lululemon Prices.

LULU stock is advancing significantly in morning trading after the company reported its Q4 results yesterday.

There’s Good News and Bad News for Digital World Acquisition

Due to the bad news that has arisen for Truth Social, the risk-to-reward ratio of DWAC stock has become unfavorable.

Meme Stocks News: What Is Going on With GME, AMC, NEGG, BBBY Stocks Today?

News about AMC and GameStop has excited investors and propelled those names, along with other meme stocks, much higher in recent days.